Pharma Foods International Co., Ltd. Logo

Pharma Foods International Co., Ltd.

Researches and sells functional ingredients and direct-to-consumer health & beauty products.

2929 | T

Overview

Corporate Details

ISIN(s):
JP3802310007
LEI:
Country:
Japan
Address:
京都市西京区御陵大原1番地49
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pharma Foods International Co., Ltd. develops and sells functional food ingredients and related consumer products. The company operates through two main segments: a functional materials business and a direct-to-consumer (B2C) business. The functional materials division researches and develops unique, science-backed ingredients with a focus on areas such as immunity, aging, and the nervous system. The B2C segment utilizes these proprietary ingredients in its e-commerce and wholesale distribution of supplements, cosmetics, and non-pharmaceutical products. Guided by a mission to create food products with pharmaceutical-like efficacy, the company aims to promote health and improve quality of life, and is also engaged in biomedical drug discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-21 08:34
Registration Form
確認書
Japanese 8.2 KB
2025-10-21 08:32
Annual Report
有価証券報告書-第28期(2024/08/01-2025/07/31)
Japanese 1.4 MB
2025-06-05 08:32
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.2 KB
2025-03-14 05:31
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-03-14 05:30
Interim Report
半期報告書-第28期(2024/08/01-2025/07/31)
Japanese 292.0 KB
2024-11-18 07:36
Share Issue/Capital Change
臨時報告書
Japanese 29.9 KB
2024-10-28 07:43
Registration Form
訂正有価証券届出書(参照方式)
Japanese 50.6 KB
2024-10-28 07:35
Post-Annual General Meeting Information
臨時報告書
Japanese 28.6 KB
2024-10-24 08:35
Registration Form
訂正有価証券届出書(参照方式)
Japanese 51.3 KB
2024-10-24 08:33
Registration Form
確認書
Japanese 8.2 KB
2024-10-24 08:32
Governance Information
内部統制報告書-第27期(2023/08/01-2024/07/31)
Japanese 22.7 KB
2024-10-24 08:30
Annual Report
有価証券報告書-第27期(2023/08/01-2024/07/31)
Japanese 1.4 MB
2024-10-22 07:50
Registration Form
有価証券届出書(参照方式)
Japanese 64.0 KB
2024-06-14 06:03
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-06-14 06:02
Quarterly Report
四半期報告書-第27期第3四半期(2024/02/01-2024/04/30)
Japanese 184.3 KB

Automate Your Workflow. Get a real-time feed of all Pharma Foods International Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharma Foods International Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharma Foods International Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Bioengineering solutions to accelerate life sciences research, from gene synthesis to cell lines.
South Korea 355690
aTYR PHARMA INC Logo
Developing novel medicines for fibrosis and inflammation using tRNA synthetase biology.
United States of America ATYR
Aura Biosciences, Inc. Logo
Developing virus-like therapies to selectively destroy solid tumors in ocular & urologic oncology.
United States of America AURA
Aurinia Pharmaceuticals Inc. Logo
Biopharma developing therapies for autoimmune and kidney diseases like lupus nephritis.
United States of America AUPH
AURORA CANNABIS INC Logo
A global producer and seller of medical and recreational cannabis and derivative products.
United States of America ACB
Autolus Therapeutics plc Logo
Develops programmed CAR T-cell therapies for cancer and autoimmune diseases.
United States of America AUTL
AVADEL PHARMACEUTICALS PLC Logo
Develops once-at-bedtime therapies for adults with narcolepsy using innovative drug delivery.
United States of America AVDL
Avidity Biosciences, Inc. Logo
Pioneering targeted RNA therapies that treat the root cause of rare muscle diseases.
United States of America RNA
Axsome Therapeutics, Inc. Logo
Biopharma company developing novel therapies for central nervous system (CNS) conditions.
United States of America AXSM
AYTU BIOPHARMA, INC Logo
Specialty pharma advancing innovative medicines for CNS diseases like MDD and ADHD.
United States of America AYTU

Talk to a Data Expert

Have a question? We'll get back to you promptly.